Report overview
This report contains market size and forecasts of Restless Legs Syndrome Pharmaceuticals in global, including the following market information:
Global Restless Legs Syndrome Pharmaceuticals Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Restless Legs Syndrome Pharmaceuticals Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Restless Legs Syndrome Pharmaceuticals companies in 2021 (%)
The global Restless Legs Syndrome Pharmaceuticals market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oral Medication Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Restless Legs Syndrome Pharmaceuticals include Boehringer Ingelheim GmbH, UCB SA, Astellas, Arbor Pharmaceuticals and Jazz Pharmaceuticals, Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Restless Legs Syndrome Pharmaceuticals manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Restless Legs Syndrome Pharmaceuticals Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Restless Legs Syndrome Pharmaceuticals Market Segment Percentages, by Type, 2021 (%)
Oral Medication
Patch Medication
Global Restless Legs Syndrome Pharmaceuticals Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Restless Legs Syndrome Pharmaceuticals Market Segment Percentages, by Application, 2021 (%)
Less than 35 Years Old
35-50 Years Old
More than 50 Years Old
Global Restless Legs Syndrome Pharmaceuticals Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Restless Legs Syndrome Pharmaceuticals Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Restless Legs Syndrome Pharmaceuticals revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Restless Legs Syndrome Pharmaceuticals revenues share in global market, 2021 (%)
Key companies Restless Legs Syndrome Pharmaceuticals sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Restless Legs Syndrome Pharmaceuticals sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Boehringer Ingelheim GmbH
UCB SA
Astellas
Arbor Pharmaceuticals
Jazz Pharmaceuticals, Inc.
